These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36062287)

  • 1. Guidelines for the Management of Cholestatic Liver Diseases (2021).
    Lu L;
    J Clin Transl Hepatol; 2022 Aug; 10(4):757-769. PubMed ID: 36062287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Guidelines on the management of cholestasis liver diseases (2021)].
    Chinese Society of Hepatology, Chinese Medical Association
    Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):253-263. PubMed ID: 35462480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guidelines on the management of cholestasis liver diseases (2021)].
    Chinese Society of Hepatology, Chinese Medical Association
    Zhonghua Nei Ke Za Zhi; 2021 Dec; 60(12):1075-1087. PubMed ID: 34856682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guidelines on the diagnosis and management of primary sclerosing cholangitis (2021)].
    Chinese Society of Hepatology, Chinese Medical Association
    Zhonghua Gan Zang Bing Za Zhi; 2022 Feb; 30(2):169-189. PubMed ID: 35359068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guidelines on the diagnosis and management of primary sclerosing cholangitis (2021)].
    Chinese Society of Hepatology, Chinese Medical Association
    Zhonghua Nei Ke Za Zhi; 2021 Dec; 60(12):1050-1074. PubMed ID: 34856681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UPDATE OF THE BRAZILIAN SOCIETY OF HEPATOLOGY RECOMMENDATIONS FOR DIAGNOSIS AND MANAGEMENT OF AUTOIMMUNE DISEASES OF THE LIVER.
    Couto CA; Terrabuio DRB; Cançado ELR; Porta G; Levy C; Silva AEB; Bittencourt PL; ; Carvalho Filho RJ; Chaves DM; Miura IK; Codes L; Faria LC; Evangelista AS; Farias AQ; Gonçalves LL; Harriz M; Lopes EPA; Luz GO; Oliveira PMC; Oliveira EMG; Schiavon JLN; Sevá-Pereira T
    Arq Gastroenterol; 2019 Aug; 56(2):232-241. PubMed ID: 31460591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.
    Moyer V; Freese DK; Whitington PF; Olson AD; Brewer F; Colletti RB; Heyman MB;
    J Pediatr Gastroenterol Nutr; 2004 Aug; 39(2):115-28. PubMed ID: 15269615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guidelines on the diagnosis and management of primary biliary cholangitis (2021)].
    Chinese Society of Hepatology, Chinese Medical Association
    Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):264-275. PubMed ID: 35462481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
    Fawaz R; Baumann U; Ekong U; Fischler B; Hadzic N; Mack CL; McLin VA; Molleston JP; Neimark E; Ng VL; Karpen SJ
    J Pediatr Gastroenterol Nutr; 2017 Jan; 64(1):154-168. PubMed ID: 27429428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update.
    Cong WM; Bu H; Chen J; Dong H; Zhu YY; Feng LH; Chen J;
    World J Gastroenterol; 2016 Nov; 22(42):9279-9287. PubMed ID: 27895416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guidelines on the diagnosis and management of primary biliary cholangitis (2021)].
    Chinese Society of Hepatology, Chinese Medical Association
    Zhonghua Nei Ke Za Zhi; 2021 Dec; 60(12):1024-1037. PubMed ID: 34856679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The management of autoimmune liver diseases: from the consensus to the guideline].
    Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jan; 24(1):3-4. PubMed ID: 26983383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From NAFLD in clinical practice to answers from guidelines.
    Nascimbeni F; Pais R; Bellentani S; Day CP; Ratziu V; Loria P; Lonardo A
    J Hepatol; 2013 Oct; 59(4):859-71. PubMed ID: 23751754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.
    Kudo M; Izumi N; Kokudo N; Matsui O; Sakamoto M; Nakashima O; Kojiro M; Makuuchi M;
    Dig Dis; 2011; 29(3):339-64. PubMed ID: 21829027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease.
    Palmer M; Regev A; Lindor K; Avigan MI; Dimick-Santos L; Treem W; Marcinak JF; Lewis JH; Anania FA; Seekins D; Shneider BL; Chalasani N
    Aliment Pharmacol Ther; 2020 Jan; 51(1):90-109. PubMed ID: 31762074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN).
    Vandenplas Y; Rudolph CD; Di Lorenzo C; Hassall E; Liptak G; Mazur L; Sondheimer J; Staiano A; Thomson M; Veereman-Wauters G; Wenzl TG; North American Society for Pediatric Gastroenterology Hepatology and Nutrition ; European Society for Pediatric Gastroenterology Hepatology and Nutrition
    J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):498-547. PubMed ID: 19745761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholestatic liver disease: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition.
    Suchy FJ; Burdelski M; Tomar BS; Sokol RJ
    J Pediatr Gastroenterol Nutr; 2002; 35 Suppl 2():S89-97. PubMed ID: 12192176
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholestatic and metabolic liver diseases: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition.
    Thompson RJ; Azevedo RA; Galoppo C; Lewindon P; McKiernan P;
    J Pediatr Gastroenterol Nutr; 2004 Jun; 39 Suppl 2():S611-5. PubMed ID: 15184760
    [No Abstract]   [Full Text] [Related]  

  • 19. [Expert consensus on antiviral therapy for HBV/HCV-related hepatocellular carcinoma: a 2021 update].
    Liver Cancer Study Group, Chinese Society of Hepatology, Chinese Medical Association
    Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):948-966. PubMed ID: 34814389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chinese guidelines on the management of liver cirrhosis].
    Chinese Society of Hepatology,Chinese Medical Association
    Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):846-865. PubMed ID: 31941240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.